FDA Inspection 1248316 — Helio Genomics, Inc.
The FDA completed an inspection of Helio Genomics, Inc. on Aug 9, 2024 in West Lafayette, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 9, 2024
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- West Lafayette, IN (United States)
Additional Details
Sponsor, Contract Research Organization